William Blair Downgrades CVS Caremark (CVS) to Market Perform
More News related to CVS
- Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in CVS Caremark Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsui
- CVS/pharmacy Kicks Off Annual Thanks and Giving(R) Campaign for the St. Jude Children's Research Hospital
- Stull, Stull & Brody Announces Class Action on Behalf of Shareholders of CVS Caremark Corporation
- Shalov Stone Bonner & Rocco LLP Announces Class Action Against CVS Caremark Corporation
- Law Offices Bernard M. Gross, P.C. Filed a Class Action Lawsuit Against Sunpower Corporation -- SPWRA, SPWRB
More News related to Downgrades
- Auriga Reiterates a 'Buy' on McDermott International (MDR); Upstream/Government Story Trumps Quarterly Noise
- Citi Upgrades Chile Stocks to Overweight, Downgrades Colombia Stocks to Neutral
- Baird Maintains a 'Neutral' Rating on Cephalon (CEPH), Reslizumab Mixed Results in EE Sets Back Potential for Upside
- Wedbush Removes McDonald's (MCD) from 'Best Ideas' List; Reiterates Outperform
- Piper Jaffray Maintains an 'Overweight' on Cephalon (CEPH); Buy on Weakness
William Blair downgrades CVS Caremark (NYSE: CVS) from Outperform to Market Perform.
To see more analyst ratings on CVS Click Here.
CVS Caremark Corporation, a pharmacy services company, provides prescriptions and related healthcare services in the United States.
Related Categories
DowngradesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
